Stock REMLIFE REMM LIFEPAR
Add to a list
To use this feature you must be a member
Log inSign up

Financials REMM LIFEPAR Bombay S.E.

Equities

REMLIFE

INE549S01028

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:56 21/06/2024 BST 		5-day change 1st Jan Change
68.4 INR -0.90% Intraday chart for REMM LIFEPAR -2.55% -31.79%
06-15 Remedium Lifecare Limited Announces the Resignation of Dhwani Desai as Company Secretary and Compliance Officer CI
05-27 Remedium Lifecare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization 1 55.62 80.28 158.4 498.6 2,655 10,937
Enterprise Value (EV) 1 45.59 74.67 255.3 484.2 2,437 11,499
P/E ratio 696 x 29 x 33.1 x 46.3 x 48.9 x 33.4 x
Yield - - - - - -
Capitalization / Revenue 35 x 2.78 x 0.18 x 0.1 x 0.52 x 0.27 x
EV / Revenue 28.7 x 2.58 x 0.28 x 0.1 x 0.48 x 0.28 x
EV / EBITDA -67.6 x 19.7 x 37.2 x 27.8 x 36.3 x 34.4 x
EV / FCF -117 x -15.3 x -2.47 x 4.37 x 12.8 x -12.5 x
FCF Yield -0.85% -6.54% -40.5% 22.9% 7.82% -8.02%
Price to Book 1.81 x 2.39 x 4.11 x 10.1 x 25.6 x 25.5 x
Nbr of stocks (in thousands) 100,800 100,800 100,800 100,800 100,800 100,800
Reference price 2 0.5518 0.7964 1.571 4.946 26.34 108.5
Announcement Date 07/09/19 07/09/20 02/09/21 27/08/22 27/06/23 04/06/24
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales 1 1.591 28.9 900.4 5,048 5,098 40,417
EBITDA 1 -0.674 3.8 6.854 17.4 67.16 334.5
EBIT 1 -0.688 3.75 6.616 17.02 65.65 334
Operating Margin -43.24% 12.97% 0.73% 0.34% 1.29% 0.83%
Earnings before Tax (EBT) 1 0.192 3.749 6.528 15.25 73.96 504.5
Net income 1 0.08 2.77 4.805 10.78 54.26 327.3
Net margin 5.03% 9.58% 0.53% 0.21% 1.06% 0.81%
EPS 2 0.000793 0.0275 0.0475 0.1068 0.5382 3.247
Free Cash Flow 1 -0.389 -4.886 -103.5 110.7 190.6 -922.2
FCF margin -24.45% -16.91% -11.49% 2.19% 3.74% -2.28%
FCF Conversion (EBITDA) - - - 636.27% 283.79% -
FCF Conversion (Net income) - - - 1,027.02% 351.26% -
Dividend per Share - - - - - -
Announcement Date 07/09/19 07/09/20 02/09/21 27/08/22 27/06/23 04/06/24
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 - - 96.9 - - 562
Net Cash position 1 10 5.61 - 14.4 219 -
Leverage (Debt/EBITDA) - - 14.14 x - - 1.679 x
Free Cash Flow 1 -0.39 -4.89 -103 111 191 -922
ROE (net income / shareholders' equity) 0.26% 8.62% 13.3% 24.5% 70.9% 123%
ROA (Net income/ Total Assets) -1.29% 6.01% 1.93% 0.81% 0.6% 1.35%
Assets 1 -6.198 46.06 248.7 1,329 9,112 24,322
Book Value Per Share 2 0.3100 0.3300 0.3800 0.4900 1.030 4.260
Cash Flow per Share 2 0.1100 0.0900 0.0800 0.1400 2.170 0.1500
Capex - 2.44 0.39 0.5 0.43 -
Capex / Sales - 8.45% 0.04% 0.01% 0.01% -
Announcement Date 07/09/19 07/09/20 02/09/21 27/08/22 27/06/23 04/06/24
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.63% 796B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.51% 628B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.10% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.95% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.66% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+3.39% 228B
NOVARTIS AG Stock Novartis AG
+10.75% 214B
AMGEN INC. Stock Amgen Inc.
+6.99% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 539561 Stock
  4. REMLIFE Stock
  5. Financials REMM LIFEPAR